Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Top Biologic Industry Leaders to Convene at Biologics World Korea 2013

Published: Friday, December 07, 2012
Last Updated: Friday, December 07, 2012
Bookmark and Share
Bringing together biologics drug innovators and bioprocess professionals from all around the world to discuss strategies in biosimilar and biobetter development, as well as cutting-edge advances in bioprocessing and bioanalytics.

The global biologics market is valued at an estimated US$149 bn and is expected to reach $230 bn by 2015. Monoclonal antibodies (mAbs) representing 32% of the market share is expected to be the fastest growing segment at 12.4% CAGR. South Korea’s biologics industry is well positioned to tap into this growing market. While Celltrion, Samsung Biologics and LG Life Sciences are grabbing the international headlines, innovative firms in South Korea such as Genexine, PharmAbcine, Alteogen and Ildong are building up an impressive innovative biologic pipeline that can rival international players.

The biologics landscape in South Korea is evolving fast. Knowing the who's and understanding the how's of the industry are crucial to stay competitive. Biologics World Korea 2013 conference will convene all these biologic players from South Korea and around the globe, to discuss the trend and challenges in biologic drug development. The conference will be chaired by Dr Byeong Doo Song, the President of Scripps Korea Antibody Institute.

The conference Keynote speaker is Dr Stanley Hong, the President of R&D of Celltrion, who led the first mAb biosimilar approval in the world. He said that the company will be interested in developing Biobetters. The company just launched its product, RemsimaTM worldwide and has already signed several distribution agreements with several leading pharma companies.

Another featured speaker is Dr Paul Coleman, the CEO of Hanwha Biologics, who successfully led the company in making its first landmark deal to license its newly developed biosimilar compound to Merck. Dr Coleman said that a key criterion in making a biosimilar globally available through partnerships is having the highest standards of quality in all aspects of the research and development processes. This is the key to success for the interest of companies who can access global markets. Hanwha Biologics has already garnered the interest of top companies in the world for its portfolio of other biosimilar compounds and is seeking to expand through further research and development of future biosimilar candidates.

The 2013 conference programme features industry visionary presentations from the Celltrion, Hanwha Biologics, Green Cross, Genexine, SK Chemicals, CJ CheilJedang, Mogam Biotech Institute, UCB Korea, Neopharm, KAIST, KRIBB, KBSI, PhamAbcine, Creagene, Merck Serono (USA), Protein Science Corporation (USA), NovImmune (Switzerland), Actokine (USA), Quest Pharma Tech (Canada), Wuxi AppTech Biologics (China) and many more. The conference programme runs on April 16-18 2013 at Sheraton Incheon Hotel. Technology providers such as BD Bioscience, Waters Korea, Dong-Il Shimadzu, Agilent Technologies and many others will also be there to showcase the latest solutions.

Since the inaugural success of Biologics World Korea 2012, the year 2013 conference will be more comprehensive to include biologic players at various stages of development. In the near term future, the innovations and partnerships will continue to drive the activities in this industry. With networking opportunities, presentation of valuable case studies and interactive discussion, the Biologics community can look forward to a fruitful gathering at the Biologics World Korea 2013. This conference aims to capture a holistic view of the issues challenging the industry, from market landscape to regulatory strategy, from bioprocessing to bioanalytics, from antibody engineering to clinical development.


Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,400+ scientific posters on ePosters
  • More Than 3,700+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

IMAPAC to Bring Together Over 150 Leading Industry Players
IMAPAC’s 3rd Biologics Korea gathering from 22-24 April 2014 in Seoul, Korea.
Wednesday, February 19, 2014
Regional Health Authorities to Meet and Discuss Russia’s 2020 Vision
Government aims for 50% of sold drugs to be manufactured in Russia by 2020.
Thursday, September 05, 2013
SE Asia Government Leaders to Discuss Move Towards Self-Sufficiency in Plasma Fractionation
Self-sufficiency is important to reduce costs, prevent blood shortages and meet the transfusion requirements of patients.
Thursday, August 29, 2013
IMAPAC Brings Together Blood Plasma Community
Upcoming Bioplasma gathering organized by IMAPAC to help facilitate the growth and innovation of quality plasma products in Asia.
Wednesday, July 17, 2013
Industry Leaders to Meet in Taiwan for Clinical Outsourcing and Collaboration Opportunities
Focused clinical trials meeting platform in Taipei, bringing together industry stakeholders, regulators and academics.
Monday, October 15, 2012
Last Days of the Early Bird Pricings for Biologics World China 2012
Keep up to date with China’s changing biopharma landscape by registering for Biologics World China 2012.
Monday, September 24, 2012
The Movement of China's Burgeoning Biologics Market
Facilitate innovation and manufacturing of affordable and high quality biologic drugs and vaccines in China.
Friday, August 24, 2012
Scientific News
Liquid Biopsies: Utilization of Circulating Biomarkers for Minimally Invasive Diagnostics Development
Market Trends in Biofluid-based Liquid Biopsies: Deploying Circulating Biomarkers in the Clinic. Enal Razvi, Ph.D., Managing Director, Select Biosciences, Inc.
10X Genomics Releases Linked-Read Data from NIST Genome Samples
Genome in a Bottle Consortium data submission for webinar presentation and public availability.
Study Sheds Light on the Causes of Cerebral Palsy
Wider use of genetic testing in children with CP should be considered.
Pitt Researchers to Monitor Resistance to HIV Drugs in Africa
Infectious diseases researchers from the University of Pittsburgh School of Medicine are leading a five-year, $5 million initiative to monitor drug resistance during the rollout of HIV prevention drugs in sub-Saharan Africa.
Environmental Epigenetics Affects Disease, Evolution
Researchers say environmental factors are having an underappreciated effect on the course of disease and evolution by prompting genetic mutations through epigenetics, a process by which genes are turned on and off independent of an organism’s DNA sequence.
Critical New Insights on DNA Repair
The enzyme fumarase is key to reversing genetic damage leading to cancer and therapy resistance.
Potential Treatment for Muscular Dystrophy
A new method for producing muscle cells could offer a better model for studying muscle diseases, such as muscular dystrophy, and for testing potential treatment options.
Nanoparticles Used to Breach Mucus Barrier in Lungs
Proof-of-concept study conducted in mice is a key step toward better treatments for lung diseases.
New Biosensors for Managing Microbial ‘Workers’
Researchers at Harvard’s Wyss Institute have unveiled new biosensors that enable scientists to more effectively control and 'communicate with' engineered bacteria.
Researchers Identify Protein in Mice that Helps Prepare for Healthy Egg-sperm Union
Protein RGS2 plays a critical role in preserving the fertilizability of the ovulated egg.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,400+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!